(MedPage Today) — At the San Antonio Breast Cancer Symposium, investigators reported findings from a retrospective study exploring whether routine blood-based immune markers could help predict response to neoadjuvant chemoimmunotherapy in early…
Source link : https://www.medpagetoday.com/meetingcoverage/sabcsfuturefocus/119162
Author :
Publish date : 2025-12-23 16:27:00
Copyright for syndicated content belongs to the linked Source.
